Structure

InChI Key NFDFQCUYFHCNBW-SCGPFSFSSA-N
Smiles C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1
InChI
InChI=1S/C18H18O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h3-12,19-20H,1-2H3/b17-3+,18-4+

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H18O2
Molecular Weight 266.34
AlogP 4.6
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 40.46
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 20.0

Bioactivity

Mechanism of Action Action Reference
Estrogen receptor alpha agonist AGONIST ISBN PubMed
Protein: Estrogen receptor alpha

Description: Estrogen receptor

Organism : Homo sapiens

P03372 ENSG00000091831
Assay Description Organism Bioactivity Reference
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 48.7 %
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 61.94 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 4.06 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 11.77 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.1 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.1 %

Cross References

Resources Reference
ChEBI 4518
ChEMBL CHEMBL1018
DrugBank DB00890
DrugCentral 870
FDA SRS RRW32X4U1F
Guide to Pharmacology 7160
KEGG C08090
PubChem 667476
SureChEMBL SCHEMBL52170
ZINC ZINC000000001283